KRAIG BIOCRAFT LABORATORIES, INC. Interest Expense Nonoperating
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Interest Expense Nonoperating of $151.40 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- KRAIG BIOCRAFT LABORATORIES, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $151.40K, a 6.63% increase year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $148.43K, a 5.76% increase year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $144.12K, a 6.06% increase year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $144.25K, a 8.55% increase year-over-year.
- KRAIG BIOCRAFT LABORATORIES, INC. interest expense nonoperating for fiscal 2023 was $484.66K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $151.40K 10-Q · filed 2026-08-13 | $299.83K 10-Q · filed 2026-08-13 | $443.95K derived: sum of 3 quarters · filed 2026-08-13 | $588.21K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $148.43K 10-Q · filed 2026-05-14 | $292.55K derived: sum of 2 quarters · filed 2026-05-14 | $436.81K derived: sum of 3 quarters · filed 2026-05-14 | $578.79K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $144.12K derived: POS AM 12 month − 10-Q 9 month · filed 2026-05-11 | $288.38K derived: sum of 2 quarters · filed 2026-05-11 | $430.36K derived: sum of 3 quarters · filed 2026-08-13 | $570.71K POS AM · filed 2026-05-11 |
| 2025-09-30 | $144.25K 10-Q · filed 2025-11-12 | $286.24K derived: sum of 2 quarters · filed 2026-08-13 | $426.59K 10-Q · filed 2025-11-12 | $562.48K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $141.99K 10-Q · filed 2026-08-13 | $282.33K 10-Q · filed 2026-08-13 | $418.22K derived: sum of 3 quarters · filed 2026-08-13 | $551.11K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $140.35K 10-Q · filed 2026-05-14 | $276.24K derived: sum of 2 quarters · filed 2026-05-14 | $409.13K derived: sum of 3 quarters · filed 2026-05-14 | $540.02K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $135.89K derived: POS AM 12 month − 10-Q 9 month · filed 2026-05-11 | $268.78K derived: sum of 2 quarters · filed 2026-05-11 | $399.67K derived: sum of 3 quarters · filed 2026-05-11 | $529.60K POS AM · filed 2026-05-11 |
| 2024-09-30 | $132.89K 10-Q · filed 2025-11-12 | $263.78K derived: sum of 2 quarters · filed 2025-11-12 | $393.71K 10-Q · filed 2025-11-12 | $519.28K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $130.89K 10-Q · filed 2025-08-14 | $260.82K 10-Q · filed 2025-08-14 | $386.39K derived: sum of 3 quarters · filed 2025-08-14 | $508.36K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $129.93K 10-Q · filed 2025-05-15 | $255.50K derived: sum of 2 quarters · filed 2025-05-15 | $377.47K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $125.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $247.54K derived: sum of 2 quarters · filed 2025-03-28 | $484.66K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $121.97K 10-Q · filed 2024-11-13 | $359.09K 10-Q · filed 2024-11-13 |